back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-25 13:58 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$715,000
+125,000 vol $5.72 each |
2,339,582 | |
| Filed 2024-04-25 13:57 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$715,000
+125,000 vol $5.72 each |
2,214,582 | |
| Filed 2024-04-25 13:57 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$714,633
+124,936 vol $5.72 each |
2,089,582 | |
| Filed 2024-04-16 18:02 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
||
| Filed 2024-04-16 18:01 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
||
| Filed 2024-04-16 17:58 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$709,125
+124,408 vol $5.70 each |
||
| Filed 2024-04-16 18:04 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$244,569
+42,907 vol $5.70 each |
101,505 | |
| Filed 2024-04-16 18:02 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
2,339,054 | |
| Filed 2024-04-16 18:01 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
2,214,054 | |
| Filed 2024-04-16 17:58 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$709,125
+124,408 vol $5.70 each |
2,089,054 | |
| Filed 2024-04-05 14:14 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$214,581
+40,487 vol $5.30 each |
862,253 | |
| Filed 2024-04-05 14:12 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-228,751.55
-40,487 vol $5.65 each |
58,598 | |
| Filed 2024-03-19 20:18 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,506
+1,039 vol $5.30 each |
821,766 | |
| Filed 2023-12-19 10:35 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,682
+1,285 vol $5.20 each |
820,727 | |
| Filed 2023-09-26 12:54 Tx date 2023-09-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$110,500
+25,000 vol $4.42 each |
819,442 | |
| Filed 2023-09-19 11:24 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,581
+1,489 vol $4.42 each |
794,442 | |
| Filed 2023-06-19 13:35 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,661
+1,354 vol $4.92 each |
792,953 | |
| Filed 2023-04-02 23:22 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$145,125
+32,686 vol $4.44 each |
99,085 | |
| Filed 2023-04-02 23:12 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$155,835
+35,098 vol $4.44 each |
1,964,646 | |
| Filed 2023-03-21 21:28 Tx date 2023-03-17 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,940,000
-250,000 vol $7.76 each |
1,929,548 | |
| Filed 2023-03-20 23:29 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,274
+1,245 vol $5.04 each |
791,599 | |
| Filed 2022-12-23 15:53 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,812
+342 vol $5.30 each |
790,354 | |
| Filed 2022-12-23 15:51 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,842
+912 vol $5.31 each |
790,012 | |
| Filed 2022-10-07 11:22 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,277
+1,115 vol $5.63 each |
789,100 | |
| Filed 2022-09-21 16:22 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,118
+2,863 vol $5.63 each |
||
| Filed 2022-09-21 16:22 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,118
+2,863 vol $5.63 each |
790,848 | |
| Filed 2022-08-16 15:58 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
2,440,068 | |
| Filed 2021-12-10 14:06 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
| Filed 2021-12-10 13:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
| Filed 2021-12-10 13:01 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
| Filed 2021-05-20 12:17 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
| Filed 2021-05-20 10:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
| Filed 2022-07-05 16:57 Tx date 2022-07-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$82,950
+15,800 vol $5.25 each |
21,678,733 | |
| Filed 2022-07-05 16:56 Tx date 2022-07-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,645
+9,800 vol $5.27 each |
21,662,933 | |
| Filed 2022-06-24 09:52 Tx date 2022-06-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Noah Ezra Goodman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$515.00
+100 vol $5.15 each |
400 | |
| Filed 2022-06-17 21:11 Tx date 2022-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,665
+1,277 vol $5.22 each |
787,985 | |
| Filed 2022-06-16 21:36 Tx date 2022-06-16 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,360
+2,000 vol $5.18 each |
42,700 | |
| Filed 2022-06-16 21:32 Tx date 2022-06-16 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$93,240
+18,000 vol $5.18 each |
21,653,133 | |
| Filed 2022-06-16 21:29 Tx date 2022-06-16 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$93,240
+18,000 vol $5.18 each |
||
| Filed 2022-05-18 16:51 Tx date 2022-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,400
+20,000 vol $5.17 each |
21,635,133 | |
| Filed 2022-05-18 16:50 Tx date 2022-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,400
+20,000 vol $5.17 each |
||
| Filed 2022-04-14 18:15 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,240
+1,200 vol $5.20 each |
22,700 | |
| Filed 2022-04-14 17:55 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,032
+19,200 vol $5.21 each |
727,284 | |
| Filed 2022-04-14 17:53 Tx date 2022-01-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,040
+18,000 vol $5.28 each |
40,500 | |
| Filed 2022-04-14 17:35 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$98,990
+19,000 vol $5.21 each |
||
| Filed 2022-04-14 17:34 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,032
+19,200 vol $5.21 each |
||
| Filed 2022-04-14 17:02 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,032
+19,200 vol $5.21 each |
||
| Filed 2022-01-04 22:04 Tx date 2022-01-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,040
+18,000 vol $5.28 each |
||
| Filed 2021-12-06 09:25 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,200
+1,000 vol $5.20 each |
||
| Filed 2021-12-06 09:24 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,032
+19,200 vol $5.21 each |
||
| Filed 2022-04-13 12:34 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+25,000 vol $10.00 each |
||
| Filed 2022-04-13 12:33 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360,000
+45,000 vol $8.00 each |
||
| Filed 2022-01-03 18:37 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+25,000 vol $10.00 each |
||
| Filed 2022-01-03 18:36 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360,000
+45,000 vol $8.00 each |
||
| Filed 2022-03-30 16:57 Tx date 2022-03-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-2,537,500
-290,000 vol $8.75 each |
2,179,548 | |
| Filed 2022-03-29 11:04 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$153,590
+29,480 vol $5.21 each |
2,469,548 | |
| Filed 2022-03-29 09:35 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$135,001
+25,912 vol $5.21 each |
66,399 | |
| Filed 2022-03-28 19:47 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$135,001
+25,912 vol $5.21 each |
||
| Filed 2022-03-28 19:47 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$135,001
+25,912 vol $5.21 each |
66,399 | |
| Filed 2022-03-28 16:39 Tx date 2022-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,273
+1,149 vol $5.46 each |
767,508 | |
| Filed 2022-01-28 10:51 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,220
+18,000 vol $5.29 each |
21,685,133 | |
| Filed 2021-11-22 16:52 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,220
+18,000 vol $5.29 each |
||
| Filed 2022-01-04 22:04 Tx date 2022-01-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,040
+18,000 vol $5.28 each |
59,700 | |
| Filed 2022-01-04 14:06 Tx date 2022-01-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,883
+1,300 vol $5.29 each |
766,359 | |
| Filed 2022-01-03 21:27 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,260
+1,000 vol $5.26 each |
21,667,133 | |
| Filed 2022-01-03 18:46 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,280
+1,000 vol $5.28 each |
||
| Filed 2022-01-03 18:46 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,280
+1,000 vol $5.28 each |
21,667,133 | |
| Filed 2022-01-03 18:45 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,699
+10,000 vol $5.27 each |
21,666,133 | |
| Filed 2022-01-03 18:44 Tx date 2021-01-06 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,058
+200 vol $5.29 each |
21,656,133 | |
| Filed 2022-01-03 18:44 Tx date 2020-12-08 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$53,300
+10,000 vol $5.33 each |
21,655,933 | |
| Filed 2022-01-03 18:43 Tx date 2020-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,250
+2,500 vol $5.30 each |
21,645,933 | |
| Filed 2022-01-03 18:42 Tx date 2020-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$53,300
+10,000 vol $5.33 each |
21,643,433 | |
| Filed 2022-01-03 18:41 Tx date 2019-06-21 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$91,080
+12,000 vol $7.59 each |
21,633,433 | |
| Filed 2022-01-03 18:40 Tx date 2019-05-21 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$73,900
+10,000 vol $7.39 each |
21,621,433 | |
| Filed 2022-01-03 18:39 Tx date 2019-03-26 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,650
+5,000 vol $7.33 each |
21,611,433 | |
| Filed 2022-01-03 18:38 Tx date 2019-03-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$96,888
+13,200 vol $7.34 each |
21,606,433 | |
| Filed 2022-01-03 18:37 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+25,000 vol $10.00 each |
21,593,233 | |
| Filed 2022-01-03 18:36 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360,000
+45,000 vol $8.00 each |
21,568,233 | |
| Filed 2021-12-23 15:44 Tx date 2021-12-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,864
+3,600 vol $5.24 each |
765,059 | |
| Filed 2021-12-17 18:19 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,699
+1,475 vol $5.22 each |
761,459 | |
| Filed 2021-12-15 14:45 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$93,060
+18,000 vol $5.17 each |
759,984 | |
| Filed 2021-12-14 15:49 Tx date 2021-12-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$147,345
+28,500 vol $5.17 each |
741,984 | |
| Filed 2021-12-14 15:49 Tx date 2021-12-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,972
+5,400 vol $5.18 each |
713,484 | |
| Filed 2021-12-10 14:06 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
2,440,068 | |
| Filed 2021-12-10 13:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
2,440,068 | |
| Filed 2021-12-10 13:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
| Filed 2021-12-10 13:01 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
| Filed 2021-12-10 13:01 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
| Filed 2021-05-20 12:17 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
| Filed 2021-05-20 12:17 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
| Filed 2021-05-20 10:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
| Filed 2021-05-20 10:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
| Filed 2021-12-06 09:25 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,200
+1,000 vol $5.20 each |
41,700 | |
| Filed 2021-12-06 09:24 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,032
+19,200 vol $5.21 each |
40,700 | |
| Filed 2021-11-24 10:04 Tx date 2021-11-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$183,573
+35,100 vol $5.23 each |
708,084 | |
| Filed 2021-11-22 16:55 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,184
+800 vol $5.23 each |
672,984 | |
| Filed 2021-11-22 16:52 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,220
+18,000 vol $5.29 each |
21,541,233 | |
| Filed 2021-11-19 13:30 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94,320
+18,000 vol $5.24 each |
672,184 | |
| Filed 2021-11-15 14:23 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94,500
+18,000 vol $5.25 each |
654,184 | |
| Filed 2021-09-20 12:30 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Noah Ezra Goodman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
300 | |
| Filed 2021-09-20 11:28 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,600
+20,000 vol $5.18 each |
21,500 | |
| Filed 2021-09-17 17:40 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,598
+1,996 vol $5.31 each |
636,184 | |
| Filed 2021-08-25 12:02 Tx date 2021-08-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,066
+200 vol $5.33 each |
634,188 | |
| Filed 2021-08-24 11:20 Tx date 2021-08-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,748
+2,200 vol $5.34 each |
633,988 | |
| Filed 2021-08-23 20:24 Tx date 2021-08-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,048
+4,300 vol $5.36 each |
631,788 | |
| Filed 2021-08-18 14:16 Tx date 2021-08-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,084
+1,500 vol $5.39 each |
1,500 | |
| Filed 2021-08-18 14:15 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-18 14:13 Tx date 2021-08-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$97,200
+18,000 vol $5.40 each |
627,488 | |
| Filed 2021-08-18 14:12 Tx date 2021-08-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$97,020
+18,000 vol $5.39 each |
609,488 | |
| Filed 2021-07-14 20:28 Tx date 2021-07-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,400
+18,000 vol $5.30 each |
591,488 | |
| Filed 2021-07-07 15:30 Tx date 2021-07-07 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94,320
+18,000 vol $5.24 each |
573,488 | |
| Filed 2021-07-02 17:00 Tx date 2021-07-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94,320
+18,000 vol $5.24 each |
555,488 | |
| Filed 2021-06-18 19:47 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,047
+1,527 vol $5.27 each |
537,488 | |
| Filed 2021-05-26 11:27 Tx date 2021-05-26 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$176,400
+33,600 vol $5.25 each |
535,961 | |
| Filed 2021-05-26 11:08 Tx date 2021-05-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,600
+2,400 vol $5.25 each |
502,361 | |
| Filed 2021-05-26 10:43 Tx date 2021-05-26 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$176,400
+33,600 vol $5.25 each |
536,261 | |
| Filed 2021-05-26 10:43 Tx date 2021-05-26 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$176,400
+33,600 vol $5.25 each |
||
| Filed 2021-05-26 10:41 Tx date 2021-05-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,175
+2,700 vol $5.25 each |
||
| Filed 2021-05-26 10:41 Tx date 2021-05-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,175
+2,700 vol $5.25 each |
502,661 | |
| Filed 2021-05-24 15:32 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$228,751
+40,487 vol $5.65 each |
40,487 | |
| Filed 2021-05-20 11:33 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$228,751
+40,487 vol $5.65 each |
||
| Filed 2021-05-20 10:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
+40,487 vol |
||
| Filed 2021-05-20 12:20 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,186,470 vol |
1,186,470 | |
| Filed 2021-05-20 12:17 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
2,440,081 | |
| Filed 2021-05-20 12:09 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:33 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$228,751
+40,487 vol $5.65 each |
40,487 | |
| Filed 2021-05-20 10:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
+40,487 vol |
||
| Filed 2021-05-20 10:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
+40,487 vol |
40,487 | |
| Filed 2021-05-20 10:49 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 10:49 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 10:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
| Filed 2021-05-20 10:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
2,440,081 | |
| Filed 2021-05-20 10:32 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,186,470 vol |
1,186,470 | |
| Filed 2021-05-20 10:32 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,186,470 vol |
||
| Filed 2014-06-06 15:23 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,186,470 vol |
||
| Filed 2014-06-06 15:23 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,186,470 vol |
||
| Filed 2021-04-06 08:40 Tx date 2021-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,544
+2,020 vol $5.22 each |
499,961 | |
| Filed 2020-12-21 18:57 Tx date 2020-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,036
+1,705 vol $5.30 each |
497,941 | |
| Filed 2020-12-04 18:08 Tx date 2020-12-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,645
+9,800 vol $5.27 each |
496,236 | |
| Filed 2020-09-28 16:48 Tx date 2020-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,539
+1,745 vol $6.04 each |
486,436 | |
| Filed 2020-07-03 15:55 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+189,848 vol |
2,393,270 | |
| Filed 2020-06-19 10:21 Tx date 2020-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,034
+1,276 vol $7.08 each |
484,691 | |
| Filed 2020-03-16 11:46 Tx date 2020-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,503
+1,739 vol $6.04 each |
483,415 | |
| Filed 2019-12-18 11:17 Tx date 2019-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,999
+1,181 vol $7.62 each |
481,676 | |
| Filed 2019-09-18 11:07 Tx date 2019-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,499
+1,353 vol $7.76 each |
480,495 | |
| Filed 2019-06-27 10:24 Tx date 2019-06-26 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,416
+3,200 vol $7.63 each |
479,142 | |
| Filed 2019-06-19 14:44 Tx date 2019-06-19 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,287
+1,222 vol $7.60 each |
475,942 | |
| Filed 2019-05-16 10:24 Tx date 2019-05-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$131,186
+17,800 vol $7.37 each |
474,720 | |
| Filed 2019-04-11 10:09 Tx date 2019-04-10 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$66,780
+9,000 vol $7.42 each |
456,920 | |
| Filed 2019-04-08 15:26 Tx date 2019-04-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,460
+3,600 vol $7.35 each |
447,920 | |
| Filed 2019-04-08 15:24 Tx date 2019-04-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,568
+3,600 vol $7.38 each |
444,320 | |
| Filed 2019-03-28 Tx date 2019-03-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,220
+5,200 vol $7.35 each |
440,720 | |
| Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$135,720
+18,000 vol $7.54 each |
381,520 | |
| Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$134,100
+18,000 vol $7.45 each |
417,520 | |
| Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$68,220
+9,000 vol $7.58 each |
363,520 | |
| Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$136,800
+18,000 vol $7.60 each |
354,520 | |
| Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$134,820
+18,000 vol $7.49 each |
399,520 | |
| Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$135,360
+18,000 vol $7.52 each |
435,520 | |
| Filed 2019-03-22 Tx date 2019-03-19 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+161,252 vol |
2,203,422 | |
| Filed 2019-03-20 Tx date 2019-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,965
+1,327 vol $7.51 each |
336,520 | |
| Filed 2018-12-19 Tx date 2018-12-17 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,794
+1,042 vol $8.44 each |
335,193 | |
| Filed 2018-09-19 Tx date 2018-09-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,023
+1,143 vol $5.27 each |
||
| Filed 2018-09-19 Tx date 2018-09-17 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,452
+1,143 vol $8.27 each |
334,151 | |
| Filed 2018-09-19 Tx date 2018-09-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,452
+1,143 vol $8.27 each |
||
| Filed 2018-09-17 Tx date 2018-09-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,452
+1,143 vol $8.27 each |
334,151 | |
| Filed 2018-09-17 Tx date 2018-09-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,023
+1,143 vol $5.27 each |
||
| Filed 2018-06-19 Tx date 2018-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,286
+1,032 vol $8.03 each |
333,008 | |
| Filed 2018-03-30 Tx date 2018-03-20 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+182,482 vol |
2,042,170 | |
| Filed 2018-03-30 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,177
+1,150 vol $7.98 each |
||
| Filed 2018-03-30 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,165
+1,150 vol $7.97 each |
331,976 | |
| Filed 2018-03-23 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Orly Anne Goodman (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-23 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Lilah Rose Goodman (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-23 Tx date 2018-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Orly Anne Goodman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$777.00
+100 vol $7.77 each |
100 | |
| Filed 2018-03-23 Tx date 2018-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Lilah Rose Goodman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$777.00
+100 vol $7.77 each |
100 | |
| Filed 2018-03-19 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,876
+906 vol $7.59 each |
||
| Filed 2018-03-19 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,106
+1,068 vol $7.59 each |
330,826 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,177
+1,150 vol $7.98 each |
331,976 | |
| Filed 2017-12-18 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,876
+906 vol $7.59 each |
330,664 | |
| Filed 2017-09-19 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,074
+926 vol $8.72 each |
329,758 | |
| Filed 2017-06-19 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,080
+822 vol $9.83 each |
328,832 | |
| Filed 2017-05-19 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+25,000 vol |
327,342 | |
| Filed 2017-05-19 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
-25,000 vol |
21,523,233 | |
| Filed 2017-05-19 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
-45,000 vol |
21,523,233 | |
| Filed 2017-05-19 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+45,000 vol |
300,175 | |
| Filed 2017-03-28 Tx date 2017-03-21 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+133,218 vol |
1,859,688 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,927
+668 vol $10.37 each |
258,010 | |
| Filed 2016-12-23 Tx date 2016-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,588
+1,062 vol $9.97 each |
257,342 | |
| Filed 2016-12-23 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,000
+25,000 vol $10.00 each |
21,593,233 | |
| Filed 2016-09-26 Tx date 2016-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,842
+538 vol $9.00 each |
256,280 | |
| Filed 2016-09-20 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Goodman, Jonathan Ross
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-20 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Goodman, Jonathan Ross
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,550
+33,000 vol $1.35 each |
49,500 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Goodman, Jonathan Ross
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,275
+16,500 vol $1.35 each |
16,500 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,853
+567 vol $8.56 each |
255,742 | |
| Filed 2016-06-03 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$360,000
+45,000 vol $8.00 each |
21,568,233 | |
| Filed 2016-03-25 Tx date 2016-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,153
+553 vol $7.51 each |
255,175 | |
| Filed 2015-12-18 Tx date 2015-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,847
+648 vol $7.48 each |
254,622 | |
| Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
1,726,470 | |
| Filed 2015-06-14 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Goodman, Jonathan Ross
4 - Director of Issuer
Holder: Knight Therapeutics Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,050,850 |